Sutacimig clinical trials

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency

This study is testing a new medicine called Sutacimig for people with a rare bleeding condition called Factor VII Deficiency. It aims to see if it's safe and how well it works after one dose to help stop bleeding.